Abstract
Using gene knockout mice of particular genes is one of the most effective methods in conducting successful study on the mode of action of target gene products in targeted organs. So called the knockout technology is now a powerful tool that can lead us to find clear understanding on difficult questions such as the effects of full antagonist against target molecules. Cacna1b ( 1B) gene knockout mouse was generated to study mechanisms of N-type calcium (Ca2+) channel. The model was able to overcome physiological obstacles in studies of N-type Ca2+ channel selective blockers, such as unspecific binding to structurally similar molecules, and failed distribution to targeted organs. In the case of N-type Ca2+ channel studies, knockout technology was successfully applied to various cardiovascular, sympathetic, nociceptive, sleepawake cycles, metabolic and neurodegenerative experiments using homozygous mutants of the 1B gene that turned out to be viable. These studies were able to confirm not only the predicted phenotypes, but were able to present completely unexpected phenotypes that are great interest for future study. Thus the outputs from the knockout mouse studies lead to gain the proof of concept as a drug for specific inhibitors of the gene products and enabled us to make further prediction of side-effects of these inhibitors in the drug discovery and development process.
Keywords: Drug Discovery Process, gene knockout mice, calcium (Ca2+) channel, phenotypes, inhibitors
Current Pharmaceutical Biotechnology
Title: The Utilization of Gene Targeting Models During in Preclinical Study of Drug Discovery Process - Example of Phenotypic and Functional Analysis of Cacna1 βGene Product
Volume: 10 Issue: 2
Author(s): Norimasa Miyamoto, Kana Namiki, Naoki Tokuhara, Mai Uesugi, Eiki Takahashi, Junro Kuromitsu and Yoshitoshi Kasuya
Affiliation:
Keywords: Drug Discovery Process, gene knockout mice, calcium (Ca2+) channel, phenotypes, inhibitors
Abstract: Using gene knockout mice of particular genes is one of the most effective methods in conducting successful study on the mode of action of target gene products in targeted organs. So called the knockout technology is now a powerful tool that can lead us to find clear understanding on difficult questions such as the effects of full antagonist against target molecules. Cacna1b ( 1B) gene knockout mouse was generated to study mechanisms of N-type calcium (Ca2+) channel. The model was able to overcome physiological obstacles in studies of N-type Ca2+ channel selective blockers, such as unspecific binding to structurally similar molecules, and failed distribution to targeted organs. In the case of N-type Ca2+ channel studies, knockout technology was successfully applied to various cardiovascular, sympathetic, nociceptive, sleepawake cycles, metabolic and neurodegenerative experiments using homozygous mutants of the 1B gene that turned out to be viable. These studies were able to confirm not only the predicted phenotypes, but were able to present completely unexpected phenotypes that are great interest for future study. Thus the outputs from the knockout mouse studies lead to gain the proof of concept as a drug for specific inhibitors of the gene products and enabled us to make further prediction of side-effects of these inhibitors in the drug discovery and development process.
Export Options
About this article
Cite this article as:
Miyamoto Norimasa, Namiki Kana, Tokuhara Naoki, Uesugi Mai, Takahashi Eiki, Kuromitsu Junro and Kasuya Yoshitoshi, The Utilization of Gene Targeting Models During in Preclinical Study of Drug Discovery Process - Example of Phenotypic and Functional Analysis of Cacna1 βGene Product, Current Pharmaceutical Biotechnology 2009; 10 (2) . https://dx.doi.org/10.2174/138920109787314999
DOI https://dx.doi.org/10.2174/138920109787314999 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Virus Diagnostics on Microarrays
Current Pharmaceutical Biotechnology Tauopathies – Focus on Changes at the Neurovascular Unit
Current Alzheimer Research COVID-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods
Anti-Cancer Agents in Medicinal Chemistry West Nile Virus NS2B/NS3 Protease As An Antiviral Target
Current Medicinal Chemistry Interferon gama induced Tryptophan Degradation Neuropsychiatric and Immunological Consequences
Current Drug Metabolism Domestic Arthropods and Their Allergens
Protein & Peptide Letters Nucleic Acid-Based Therapeutics for Glioblastoma
Anti-Cancer Agents in Medicinal Chemistry Caring for HIV-Infected Patients in the ICU in The Highly Active Antiretroviral Therapy Era
Current HIV Research Guinea Pig Model of Infectious Disease - Viral Infections
Current Drug Targets Current Therapeutic Options for Alzheimers Disease
Current Genomics Polyphenols Beyond Barriers: A Glimpse into the Brain
Current Neuropharmacology Functional Selectivity in Cannabinoid Signaling
Current Molecular Pharmacology How Does Indoleamine 2,3-Dioxygenase Contribute to HIV-Mediated Immune Dysregulation
Current Drug Metabolism Identification of HIV Inhibitors Guided by Free Energy Perturbation Calculations
Current Pharmaceutical Design Mathematical Models for the Management of Helminth Parasites: From Biological Processes to the Evolution of Anthelmintic Resistance
Anti-Infective Agents in Medicinal Chemistry An Update on the Management of Severe Cutaneous Drug Hypersensitivity Reactions
Current Pharmaceutical Design Drug Discovery in Enteroviral Infections
Infectious Disorders - Drug Targets Novel and Viable Acetylcholinesterase Target Site for Developing Effective and Environmentally Safe Insecticides
Current Drug Targets Advancement in Nanoparticle-based Biosensors for Point-of-care <i>In vitro</i> Diagnostics
Current Topics in Medicinal Chemistry Applications of Gene Therapy to the Treatment of Chronic Pain
Current Gene Therapy